SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Gross profit as a percentage of revenue
Latest
0.00%
↓ 100% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
7.69%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | +100.0% |
| 2024 | -262.41% | -290.1% |
| 2023 | -67.26% | -178.0% |
| 2022 | 86.23% | -11.4% |
| 2021 | 97.28% | -2.7% |
| 2020 | 100.00% | 0.0% |
| 2019 | 100.00% | - |